NCT00219037View on ClinicalTrials.gov

Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

1,955

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Hypertension
Interventions
DRUG

aliskiren

Trial Locations (1)

Unknown

Investigative Sites

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY